International biotechnology search firm moves to larger Leeds offices

An international biotechnology search firm is moving to new larger headquarters in Leeds as it looks to double the size of its workforce in 2022.

Hartmann Young is moving to new 3000 sq ft headquarters in Toronto Square Leeds as it doubled its staff numbers to over 25 specialist consultants in the last 12 months.

Hartmann Young also opened a new office in Mayfair, London, to accommodate a larger team in the capital. The company serves an international client base and has seen revenues leap from £1.5m last year to £4.5m this financial year.

Hartmann Young expects to recruit another 25 consultants in 2022 to support its continued growth, focusing on overseas markets to support its operations in the biotechnology hubs of Boston and California.

Andrew Buxton, CEO of Hartman Young, said: “Our growth over the last 12 months has been staggering. We’ve built a strong international reputation in the biotechnology and life sciences sectors thanks to our collaborative and team-focused approach.”

“We utilise our broad experience and specialist, global network to offer our clients a turnkey solution to their talent acquisition and retention plans. Our investment in training and technology mean we add real value to the recruitment process, with clients regarding us as a true partner to help fuel their rapid or strategic growth plans.”

Hartmann Young offers consultants state-of-the-art offices, extended lunch breaks and unlimited holidays for personal health and wellbeing, alongside a technology package that includes the latest Apple equipment and leading software.

Consultants at Hartmann Young undergo extensive training to give them an in-depth understanding of the relevant industry sector, resulting in a team that has a broad range of sector-specific knowledge to enable them to select the highest quality candidates for their clients.

In addition, the company benchmarks salaries in its sector to offer market-leading compensation packages and operates a four and a half day week.

The global biotechnology market was estimated at $752.88bn in 2020 and is expected to reach $1,006.68bn in 2021. The UK BioIndustry Association (BIA) estimates that UK biotech companies raised a record £2.8bn in equity finance in 2020.

The UK is considered to be the third global life sciences cluster, rivalling San Francisco and Boston, Massachusetts, and is home to 6,300 life science companies.

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →